Asia Reg Roundup: Updates From China, Taiwan And Korea
Executive Summary
An end-of-year flurry of regulatory activity in the Asian medtech markets has kept industry on its toes, with initiatives in China, Taiwan and Korea, among other regions. But as Asia Regulatory Professional Association (ARPA) Secretary Jack Wong and ARQon consultant May Ng observe in this December update for Medtech Insight, governments and companies in certain markets might benefit from a little more pressure in view of the regulatory tasks they face.
You may also be interested in...
South Korea Roundup: Augmented Reality Device Guidelines, Digital, UDI And IVD Updates
The devices regulator has sought private sector input in updating AR/VR guidelines, but needs to do more on telemedicine integration. Mixed experiences are reported on UDI and the new IVD regulation.
GDP And UDI On List Of Regulatory Changes Under Taiwan Medical Device Act
Taiwan’s Medical Device Act was enforced on 1 May, bringing changes to good distribution practice and laying the foundation for UDI regulations.
UDI Requirements Come to Brazil
A new regulation from Brazilian device regulator ANVISA will require some high-risk devices to carry Unique Device Identifiers. The rule, which will come into effect in 2020, is the first time the country has mandated UDIs.